Parallax Volatility Advisers
INFI

Parallax Volatility Advisers’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Parallax Volatility Advisers’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-76,600
Closed -$247K – 4349
2017
Q1 		$247K Sell
76,600
-360,900
-82% -$888K ﹤0.01% 1857
2016
Q4 		$591K Buy
+437,500
New +$571K ﹤0.01% 1433

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Parallax Volatility Advisers's INFI Position: Q2 2017 in Review

Parallax Volatility Advisers sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2017, closing a stake of 9,848 shares — an estimated $32K sold.

Parallax Volatility Advisers first reported a position in INFI in Q4 2016 and held it in 2 quarters. The position peaked at $99K in Q4 2016. 74 funds tracked by Wall St. Rank hold INFI as of Q2 2017.

  • Parallax Volatility Advisers reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • Parallax Volatility Advisers sold 9,848 Infinity Pharmaceuticals, Inc. shares in Q2 2017, an estimated $32K.
  • Parallax Volatility Advisers first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2016 and held it in 2 quarters.
  • Parallax Volatility Advisers's Infinity Pharmaceuticals, Inc. position peaked at $99K in Q4 2016.
  • 74 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2017.

Based on Parallax Volatility Advisers's 13F filing for Q2 2017, filed 14 Aug 2017.